357 related articles for article (PubMed ID: 38730462)
1. Contribution of extracellular vesicles for the pathogenesis of retinal diseases: shedding light on blood-retinal barrier dysfunction.
Martins B; Pires M; Ambrósio AF; Girão H; Fernandes R
J Biomed Sci; 2024 May; 31(1):48. PubMed ID: 38730462
[TBL] [Abstract][Full Text] [Related]
2. Implication of Hyperhomocysteinemia in Blood Retinal Barrier (BRB) Dysfunction.
Tawfik A; Samra YA; Elsherbiny NM; Al-Shabrawey M
Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32751132
[TBL] [Abstract][Full Text] [Related]
3. The blood-retina barrier in health and disease.
O'Leary F; Campbell M
FEBS J; 2023 Feb; 290(4):878-891. PubMed ID: 34923749
[TBL] [Abstract][Full Text] [Related]
4. Blood-retinal barrier.
Cunha-Vaz J; Bernardes R; Lobo C
Eur J Ophthalmol; 2011; 21 Suppl 6():S3-9. PubMed ID: 23264323
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Oxidative Stress on Blood-Retinal Barrier Physiology in Age-Related Macular Degeneration.
Tisi A; Feligioni M; Passacantando M; Ciancaglini M; Maccarone R
Cells; 2021 Jan; 10(1):. PubMed ID: 33406612
[TBL] [Abstract][Full Text] [Related]
6. Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management.
Kaur C; Foulds WS; Ling EA
Prog Retin Eye Res; 2008 Nov; 27(6):622-47. PubMed ID: 18940262
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions.
Klaassen I; Van Noorden CJ; Schlingemann RO
Prog Retin Eye Res; 2013 May; 34():19-48. PubMed ID: 23416119
[TBL] [Abstract][Full Text] [Related]
8. N-Methyl-D-aspartate receptor activation, novel mechanism of homocysteine-induced blood-retinal barrier dysfunction.
Tawfik A; Mohamed R; Kira D; Alhusban S; Al-Shabrawey M
J Mol Med (Berl); 2021 Jan; 99(1):119-130. PubMed ID: 33159240
[TBL] [Abstract][Full Text] [Related]
9. Extracellular vesicles of human diabetic retinopathy retinal tissue and urine of diabetic retinopathy patients are enriched for the junction plakoglo bin protein.
Mighty J; Rubio-Navarro A; Shi C; Zhou J; Flores-Bellver M; Heissel S; Onwumere O; Einbond L; Gharbaran R; Casper DS; Benito-Martin A; Redenti S
Front Endocrinol (Lausanne); 2022; 13():1077644. PubMed ID: 36686464
[TBL] [Abstract][Full Text] [Related]
10. Influx Transport of Cationic Drug at the Blood-Retinal Barrier: Impact on the Retinal Delivery of Neuroprotectants.
Kubo Y; Akanuma SI; Hosoya KI
Biol Pharm Bull; 2017; 40(8):1139-1145. PubMed ID: 28768994
[TBL] [Abstract][Full Text] [Related]
11. Roles of Drug Transporters in Blood-Retinal Barrier.
Liu L; Liu X
Adv Exp Med Biol; 2019; 1141():467-504. PubMed ID: 31571172
[TBL] [Abstract][Full Text] [Related]
12. IL-10-induced modulation of macrophage polarization suppresses outer-blood-retinal barrier disruption in the streptozotocin-induced early diabetic retinopathy mouse model.
Lee SJ; Noh SE; Jo DH; Cho CS; Park KS; Kim JH
FASEB J; 2024 May; 38(9):e23638. PubMed ID: 38713098
[TBL] [Abstract][Full Text] [Related]
13. Regulation of blood-retinal barrier cell-junctions in diabetic retinopathy.
Rudraraju M; Narayanan SP; Somanath PR
Pharmacol Res; 2020 Nov; 161():105115. PubMed ID: 32750417
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
[TBL] [Abstract][Full Text] [Related]
15. Natural flavonoid galangin alleviates microglia-trigged blood-retinal barrier dysfunction during the development of diabetic retinopathy.
Zhang T; Mei X; Ouyang H; Lu B; Yu Z; Wang Z; Ji L
J Nutr Biochem; 2019 Mar; 65():1-14. PubMed ID: 30597356
[TBL] [Abstract][Full Text] [Related]
16. TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis.
Huang H; Gandhi JK; Zhong X; Wei Y; Gong J; Duh EJ; Vinores SA
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1336-44. PubMed ID: 21212173
[TBL] [Abstract][Full Text] [Related]
17. Endothelial CYP2J2 overexpression restores the BRB via METTL3-mediated ANXA1 upregulation.
Zhao B; Huang J; Lou X; Yao K; Ye M; Mou Q; Wen Z; Duan Q; Zhang H; Zhao Y
FASEB J; 2022 Nov; 36(11):e22619. PubMed ID: 36269280
[TBL] [Abstract][Full Text] [Related]
18. Extracellular Vesicles and MicroRNA: Putative Role in Diagnosis and Treatment of Diabetic Retinopathy.
Martins B; Amorim M; Reis F; Ambrósio AF; Fernandes R
Antioxidants (Basel); 2020 Aug; 9(8):. PubMed ID: 32759750
[TBL] [Abstract][Full Text] [Related]
19. The Blood-Retinal Barrier in the Management of Retinal Disease: EURETINA Award Lecture.
Cunha-Vaz J
Ophthalmologica; 2017; 237(1):1-10. PubMed ID: 28152535
[TBL] [Abstract][Full Text] [Related]
20. Endothelial Cell-Specific Inactivation of TSPAN12 (Tetraspanin 12) Reveals Pathological Consequences of Barrier Defects in an Otherwise Intact Vasculature.
Zhang C; Lai MB; Pedler MG; Johnson V; Adams RH; Petrash JM; Chen Z; Junge HJ
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2691-2705. PubMed ID: 30354230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
